Shreyas Kalantri
Louisville, KYNPI 1902428907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,065, 5.7 times the $708 reported in 2023.
Across 313 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$1K
- Sanofi$704
- Novartis$660
- Pfizer$434
- Incyte Corporation$434
- Regeneron Healthcare Solutions, Inc.$406
- plus $4K from 38 others
What the payments were for
- Food & beverage$7,25993%
- Education$5467%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISQALI$140
- LIBTAYO$126
- PANHEMATIN$125
- OJJAARA$116
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.